Evidence map›Paper›PMID 35321509›Full record

ArticleFrontiers in neurology2022

Novel Frameshift Heterozygous Mutation in

Chao Zhang, Xiaowei Zhu, Zeyu Zhu, Ruilong Ni, Taotao Liu, Haoran Zheng, Shihua Liu, Li Cao, Ping Zhong, Wotu Tian

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Chao ZhangSuzhou Hospital of Anhui Medical University Suzhou Municipal Hospital of Anhui Province, Suzou, China.
Xiaowei ZhuSuzhou Hospital of Anhui Medical University Suzhou Municipal Hospital of Anhui Province, Suzou, China.
Zeyu ZhuDepartment of Neurology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China.
Ruilong NiDepartment of Neurology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China.
Taotao LiuDepartment of Neurology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China.
Haoran ZhengDepartment of Neurology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China.
Shihua LiuSuzhou Hospital of Anhui Medical University Suzhou Municipal Hospital of Anhui Province, Suzou, China.
Li CaoSuzhou Hospital of Anhui Medical University Suzhou Municipal Hospital of Anhui Province, Suzou, China.
Ping ZhongSuzhou Hospital of Anhui Medical University Suzhou Municipal Hospital of Anhui Province, Suzou, China.
Wotu TianDepartment of Neurology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hereditary spastic paraplegia (HSP) represents a group of rare inherited neurodegenerative conditions and is characterized by progressive lower limb spasticity. Ubiquitin-associated protein 1 (

Indexed as

case reporthereditary spastic paraplegiaspastic paraplegia-80UBAP1whole exome sequencing

Identifiers

PMID35321509
PMCPMC8936171

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.